alexa Hodgkin's Disease Scholarly Journal|OMICS Group|Cancer Science And Therapy

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Hodgkin's Disease Scholarly Journal

Hodgkin lymphoma, also known as Hodgkin's lymphoma or Hodgkin's disease, is a type of lymphoma, in which cancer originates from white blood cells called lymphocytes. Biotherapy options have emerged for patients with B-lineage Non-Hodgkins Lymphoma (NHL). A series of novel mAbs with specificity for a variety of surface antigens are currently under evaluation. Rituximab used both for biotherapy of patients with B-lineage NHL who experience a recurrence of their disease after frontline therapy as well as for frontline treatment of B-lineage NHL patients who are at high risk to experience a recurrence after chemotherapy. Hodgkin Lymphoma (HL) shows a 3rd month anti-TNF therapy which needs to be modified and pursue immunosuppressive therapy with anti-TNF drugs, which were also used in the treatment of rheumatic diseases. Scholarly journal is a peer-reviewed journal in which scholarship relating to a particular academic discipline is published. Scholarly journals serve as forums for the introduction and presentation for scrutiny of new research, and the critique of existing research. Content typically takes the form of articles presenting original research, review articles, and book reviews. The term Scholarly journal applies to scholarly publications in all fields; this article discusses the aspects common to all academic field journals.
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords